CareDx, Inc
CareDx, Inc., a leading innovator in the field of transplant diagnostics, is headquartered in the United States. Founded in 1998, the company has established itself as a key player in the biotechnology industry, focusing on improving the lives of transplant patients through advanced genomic solutions. With a strong presence in major operational regions across North America and Europe, CareDx offers unique products and services, including AlloSure and AlloMap, which provide non-invasive monitoring of organ transplant health. These offerings are distinguished by their ability to deliver precise, actionable insights that enhance patient care and outcomes. Recognised for its commitment to innovation, CareDx has achieved significant milestones, positioning itself as a trusted partner in transplant medicine. The company continues to lead the market with its cutting-edge technologies, contributing to the evolving landscape of personalised healthcare.
DitchCarbon Score
How does CareDx, Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CareDx, Inc's score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CareDx, Inc's reported carbon emissions
In 2024, CareDx, Inc. reported carbon emissions of approximately 456,000 kg CO2e from Scope 2 emissions in the US. This figure is part of a total of about 525,000 kg CO2e for Scope 1 and 2 emissions globally. In the previous year, 2023, the company recorded about 1,048,000 kg CO2e in Scope 2 emissions in the US and a total of approximately 1,138,000 kg CO2e for Scope 1 and 2 emissions globally. CareDx has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges. The company’s emissions data is not cascaded from any parent organisation, indicating that these figures are independently reported. Overall, CareDx's commitment to addressing climate change is reflected in its emissions reporting, although it currently lacks defined reduction strategies or targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CareDx, Inc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
